Chemed - 15 Year Stock Price History | CHE
Historical daily share price chart and data for Chemed since 2011 adjusted for splits and dividends. The latest closing stock price for Chemed as of June 11, 2026 is 420.87.
- The all-time high Chemed stock closing price was 644.43 on March 19, 2024.
- The Chemed 52-week high stock price is 562.77, which is 33.7% above the current share price.
- The Chemed 52-week low stock price is 365.21, which is 13.2% below the current share price.
- The average Chemed stock price for the last 52 weeks is 438.93.
| Chemed Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 421.6075 | 422.6770 | 477.8870 | 368.0870 | 420.8700 | -1.37% |
| 2025 | 502.4431 | 524.1850 | 615.3460 | 410.0850 | 426.7370 | -18.87% |
| 2024 | 572.2741 | 578.5540 | 644.4350 | 513.7400 | 526.0120 | -9.11% |
| 2023 | 527.7997 | 500.2300 | 586.8970 | 483.5430 | 578.7320 | 14.90% |
| 2022 | 476.6376 | 518.5070 | 518.5070 | 426.4690 | 503.7030 | -3.22% |
| 2021 | 471.8881 | 518.4730 | 545.3880 | 400.6450 | 520.4650 | -0.38% |
| 2020 | 459.3750 | 431.1290 | 528.5760 | 344.1460 | 522.4260 | 21.59% |
| 2019 | 359.8240 | 269.7470 | 431.7750 | 259.1210 | 429.6720 | 55.58% |
| 2018 | 291.8457 | 239.8620 | 324.0100 | 239.8620 | 276.1720 | 17.01% |
| 2017 | 193.1897 | 156.5890 | 240.3960 | 156.5890 | 236.0160 | 52.32% |
| 2016 | 133.2824 | 140.7230 | 155.5260 | 121.1050 | 154.9470 | 7.89% |
| 2015 | 125.0951 | 99.9378 | 152.1890 | 96.3006 | 143.6180 | 42.74% |
| 2014 | 89.5804 | 70.6751 | 105.5270 | 69.1933 | 100.6140 | 39.13% |
| 2013 | 68.9922 | 66.1320 | 76.5763 | 59.8267 | 72.3174 | 12.88% |
| 2012 | 58.4979 | 48.3830 | 66.6780 | 47.2746 | 64.0677 | 35.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |